Venture capital funding deals in the UK experienced a 12% decrease in value during the first half of the year.
The venture capital landscape experienced a significant shift in the first half of 2025, with varying trends observed in major global markets compared to the same period in 2024.
In the United States, VC funding surged by about 190% to approximately USD 97.2 billion, primarily driven by the booming AI sector in Silicon Valley. Despite a 20.2% decrease in the number of deals, the average round size grew markedly, especially in mid- and late-stage rounds.
On the other hand, the United Kingdom saw a decline in VC funding, with a 15.5% decrease to USD 7.1 billion in H1 2025 compared to H1 2024. The UK experienced fewer deals (a 10.1% decrease) and overall lower invested capital, reflecting ongoing macroeconomic uncertainty and slower startup capital flows.
China, which ranks second, also saw a notable decline in both VC metrics, with deal volume dropping by approximately 6% and deal value plummeting by over 40% in H1 2025 compared to H1 2024.
Despite the decline in UK VC funding, the country remains a significant player in the global venture capital ecosystem. Notable funding rounds included Isomorphic Labs raising $600 million, Rapyd securing $300 million, Verdiva Bio obtaining $411 million, and CMR Surgical receiving $200 million in VC funding during H1 2025.
Aurojyoti Bose, Lead Analyst at GlobalData, stated that the decline in UK VC funding indicates challenges faced by startups in attracting investments. Bose also noted that certain sectors, particularly technology and healthcare, continue to attract investor interest within the UK VC ecosystem.
The decline in activity is indicative of a cautious approach by investors amid economic uncertainties and challenging market conditions. Europe overall faced cooling VC activity due to high interest rates and macroeconomic uncertainty. Emerging markets like MENA showed growth in both funding and deal count, contrasting the global trend of deal count reduction.
In summary, the US experienced a strong rebound and expansion in VC funding propelled by AI, while the UK saw a decline, and China remained subdued in H1 2025 compared to H1 2024. Globally, fewer but larger funding rounds dominated, reflecting a shift toward later-stage and capital-intensive investments.
References:
- TechCrunch
- GlobalData
- CB Insights
- PitchBook
- ArabNet
In the UK, despite a decline in overall VC funding, sectors like technology continue to attract investor interest, as demonstrated by notable funding rounds like Isomorphic Labs receiving $600 million, Rapyd securing $300 million, Verdiva Bio obtaining $411 million, and CMR Surgical receiving $200 million.
In the global venture capital landscape, the tech sector, particularly in the UK, continues to leverage technological advancements for financing, a testament to its resilience and potential for growth even in an uncertain economic climate.
